DEMLOVÁ, Regina and Karolína GRODOVÁ. ZPRÁVA O PRŮBĚHU KLINICKÉHO HODNOCENÍ FAR-RMS (23. 11. 2022 – 29. 5. 2023) (REPORT ON THE PROGRESS OF THE FAR-RMS CLINICAL EVALUATION (23/11/2022 – 29/05/2023)). NA. Brno: MU LF/MŠMT/FN BRNO, 2023, 5 pp. NA.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name ZPRÁVA O PRŮBĚHU KLINICKÉHO HODNOCENÍ FAR-RMS (23. 11. 2022 – 29. 5. 2023)
Name in Czech ZPRÁVA O PRŮBĚHU KLINICKÉHO HODNOCENÍ FAR-RMS (23. 11. 2022 – 29. 5. 2023)
Name (in English) REPORT ON THE PROGRESS OF THE FAR-RMS CLINICAL EVALUATION (23/11/2022 – 29/05/2023)
Authors DEMLOVÁ, Regina (203 Czech Republic, guarantor) and Karolína GRODOVÁ (203 Czech Republic, belonging to the institution).
Edition NA. Brno, 5 pp. NA, 2023.
Publisher MU LF/MŠMT/FN BRNO
Other information
Original language Czech
Type of outcome Research report
Field of Study 30230 Other clinical medicine subjects
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW FaR-RMS
RIV identification code RIV/00216224:14110/23:00133152
Organization unit Faculty of Medicine
Keywords (in Czech) FaR-RMS; RhabdoMyoSarcoma; children; adults; annual report
Keywords in English FaR-RMS; RhabdoMyoSarcoma; children; adults; annual report
Tags FN Brno, interim report, MU, RIV, user
Tags International impact
Changed by Changed by: Bc. Hana Vladíková, BBA, učo 244692. Changed: 23/1/2024 13:01.
Abstract
FaR-RMS je mezinárodní, randomizovaná, otevřená, multicentrická klinická studie prováděná ve Fakultní nemocnicí Brno a Fakultní nemocnici v Motole. Primárním cílem studie je vylepšit prognózu pacientů s rhabdomyosarkomem. V České republice bude probíhat pouze na dětských klinikách.
Abstract (in English)
FaR-RMS is an international, randomized, open, multicenter clinical study conducted at the University Hospital in Brno and the University Hospital in Motol. The primary objective of the study is to improve the prognosis of patients with rhabdomyosarcoma. In the Czech Republic, it will take place only in children's clinics.
Links
90249, large research infrastructuresName: CZECRIN IV
PrintDisplayed: 9/7/2024 01:01